HCP Ed-UK

SGLT2 Inhibitors: Beyond Glycaemic Control
2026-03-12 12:45 - 14:00 UTC | Online Webinar
Beyond HbA1c: Modern Diabetes Care in Primary Care Nursing

The first in a series of three one-hour Lunch & Learn sessions designed for nurses working in general practice, focusing on contemporary diabetes care beyond glycaemic control.

Session 1 SGLT2 Inhibitors: Beyond Glycaemic Control

Session overview/content:This session explores the role of SGLT2 inhibitors in modern diabetes care, with a particularfocus on their cardiovascular and renal benefits. It will move beyond glucose lowering to helpnurses understand why these medications are increasingly used in people with type 2 diabeteswho have, or are at risk of, heart failure and chronic kidney disease. Practical nursingconsiderations, monitoring, and patient conversations will be highlighted throughout.

Aim:To enable primary care nurses to understand the non-glycaemic benefits of SGLT2 inhibitorsand their role in improving cardiovascular and renal outcomes in people with type 2 diabetes.

Learning objectives:

Understand key nursing considerations, including side effects, sick day rules, and

patient counselling

By the end of this session, participants will be able to:

Describe how SGLT2 inhibitors work beyond glucose lowering

Explain the cardiovascular benefits of SGLT2 inhibitors, particularly in heart failure

Recognise the renal protective effects of SGLT2 inhibitors in people with type 2

diabetes

Identify which patients in primary care are most likely to benefit from SGLT2 inhibitor

therapy

Speaker: Tracy Kirk – Director of Education at the Primary Care Respiratory Training Centre.
